Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001262463-16-000987
Filing Date
2016-06-30
Accepted
2016-06-30 16:45:38
Documents
81
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plpl2015.htm 10-K 704062
2 EXHIBIT 31.1 ex311.htm EX-31 7859
3 EXHIBIT 31.2 ex312.htm EX-31 7566
4 EXHIBIT 32.1 ex321.htm EX-32 3973
5 EXHIBIT 32.2 ex322.htm EX-32 3983
  Complete submission text file 0001262463-16-000987.txt   5126876

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plpl-20150630.xml EX-101.INS 801820
7 XBRL SCHEMA FILE plpl-20150630.xsd EX-101.SCH 61161
8 XBRL CALCULATION FILE plpl-20150630_cal.xml EX-101.CAL 79782
9 XBRL DEFINITION FILE plpl-20150630_def.xml EX-101.DEF 347397
10 XBRL LABEL FILE plpl-20150630_lab.xml EX-101.LAB 393569
11 XBRL PRESENTATION FILE plpl-20150630_pre.xml EX-101.PRE 386436
Mailing Address 1451 NORTH 200 EAST SUITE #130C LOGAN UT 98102
Business Address 1451 NORTH 200 EAST SUITE #130C LOGAN UT 98102 801-209-1227
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

EIN.: 453642179 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-51206 | Film No.: 161743635
SIC: 2834 Pharmaceutical Preparations